...
首页> 外文期刊>Cancer Management and Research >Prognostic Significance of PD-L1 Expression and Its Tumor-Intrinsic Functions in Hypopharyngeal Squamous Cell Carcinoma
【24h】

Prognostic Significance of PD-L1 Expression and Its Tumor-Intrinsic Functions in Hypopharyngeal Squamous Cell Carcinoma

机译:PD-L1表达及其肿瘤内在功能在白血病鳞状细胞癌中的预后意义

获取原文
           

摘要

Purpose: The expression of programmed death-ligand 1 (PD-L1) is common in various solid human cancers and it is an important therapeutic target. However, the expression pattern, clinical significance and potential mechanism of PD-L1 in hypopharyngeal squamous cell carcinoma (HSCC) are still lacking. Methods: PD-L1 expression in HSCC tumor tissues and paired adjacent hypopharyngeal mucosal tissues was detected using immunohistochemistry assay, and the clinical significance of PD-L1 in HSCC was characterized. In vitro assays including cell viability assays, migration assays, invasion assays as well as Western blot assays were performed to illuminate the biological functions and underlying molecular mechanisms of PD-L1 in HSCC development. Results: PD-L1 expression was detected in HSCC samples but we found no positive expression in matched normal hypopharyngeal mucosal tissues. The levels of PD-L1 expression were significantly correlated with advanced clinical progression and poor patient survival. Multivariable analysis of Cox model showed that PD-L1 expression was an independent predictor for the prognosis of HSCC patients. Functional experiments showed that the ectopic expression of PD-L1 markedly influenced the proliferation, migration and invasion of FaDu cells in vitro. Mechanistically, investigations demonstrated that PD-L1 could promote the epithelial–mesenchymal transition of FaDu cells. Meanwhile, PD-L1 knockdown inhibited, while PD-L1 overexpression activated the Akt-mTOR signaling pathway in FaDu cells. The EMT induced by PD-L1 overexpression could be reversed by the Akt inhibitor. Conclusion: In summary, the expression of PD-L1 can act as a significant biomarker for the adverse clinicopathological features and poor prognosis of patients with HSCC. PD-L1 can promote the proliferation, migration and invasion of FaDu cells and consequently enhance the aggressiveness. Moreover, PD-L1 induces EMT through AKT-mTOR signaling pathway. These suggest that PD-L1 has important tumor-intrinsic functions independent of its immunopathogenic effects.
机译:目的:编程死亡 - 配体1(PD-L1)的表达在各种固体人癌中是常见的,并且是一个重要的治疗靶标。然而,仍然缺乏PD-L1的表达模式,临床意义和潜在机制(HSCC)。方法:使用免疫组织化学测定检测HSCC肿瘤组织中的PD-L1表达和配对相邻的阴性阴离子粘膜组织,其特征在于HSCC的PD-L1临床意义。在包括细胞活力测定的体外测定,进行迁移测定,侵袭测定以及Western印迹测定以照亮HSCC发育中PD-L1的生物功能和潜在的分子机制。结果:在HSCC样品中检测到PD-L1表达,但在匹配的正常性阴性粘膜组织中发现没有阳性表达。 PD-L1表达水平与晚期临床进展和患者存活率差异显着相关。 Cox模型的多变量分析表明,PD-L1表达是HSCC患者预后的独立预测因子。功能实验表明,PD-L1的异位表达明显影响了在体外的FADU细胞的增殖,迁移和侵袭。机械地,研究表明PD-L1可以促进FADU细胞的上皮 - 间充质转换。同时,PD-L1敲低抑制,而PD-L1过表达在FADU细胞中激活AKT-MTOR信号传导途径。 PD-L1过表达诱导的EMT可由AKT抑制剂反转。结论:总之,PD-L1的表达可以作为具有不良临床病理特征和HSCC患者的不良预后的重要生物标志物。 PD-L1可以促进FADU细胞的增殖,迁移和侵袭,从而提高侵略性。此外,PD-L1通过AKT-MTOR信号传导路径引导EMT。这些表明PD-L1具有重要的肿瘤内在功能,与其免疫致病作用无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号